DE602007013450D1 - Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin - Google Patents

Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin

Info

Publication number
DE602007013450D1
DE602007013450D1 DE602007013450T DE602007013450T DE602007013450D1 DE 602007013450 D1 DE602007013450 D1 DE 602007013450D1 DE 602007013450 T DE602007013450 T DE 602007013450T DE 602007013450 T DE602007013450 T DE 602007013450T DE 602007013450 D1 DE602007013450 D1 DE 602007013450D1
Authority
DE
Germany
Prior art keywords
compounds
gain
medicine
application
ampa receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007013450T
Other languages
English (en)
Inventor
Daniel Marcus Bradley
Wai Ngor Chan
Kevin Michael Thewlis
Simon Edward Ward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0621967A external-priority patent/GB0621967D0/en
Priority claimed from GB0717262A external-priority patent/GB0717262D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602007013450D1 publication Critical patent/DE602007013450D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
DE602007013450T 2006-11-03 2007-11-01 Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin Active DE602007013450D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0621967A GB0621967D0 (en) 2006-11-03 2006-11-03 Compounds
GB0717262A GB0717262D0 (en) 2007-09-05 2007-09-05 Compounds
PCT/EP2007/061794 WO2008053031A1 (en) 2006-11-03 2007-11-01 Compounds which potentiate ampa receptor and uses thereof in medicine

Publications (1)

Publication Number Publication Date
DE602007013450D1 true DE602007013450D1 (de) 2011-05-05

Family

ID=39099804

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007013450T Active DE602007013450D1 (de) 2006-11-03 2007-11-01 Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin

Country Status (6)

Country Link
US (1) US20100137276A1 (de)
EP (1) EP2086643B1 (de)
JP (1) JP2010508328A (de)
AT (1) ATE502675T1 (de)
DE (1) DE602007013450D1 (de)
WO (1) WO2008053031A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0711089D0 (en) * 2007-06-08 2007-07-18 Glaxo Group Ltd Compounds
GB0711088D0 (en) * 2007-06-08 2007-07-18 Glaxo Group Ltd Compounds
JP6134654B2 (ja) * 2012-02-08 2017-05-24 武田薬品工業株式会社 複素環化合物およびその用途
WO2016176449A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
CN107835814B (zh) 2015-04-29 2021-07-23 詹森药业有限公司 氮杂苯并咪唑及其作为ampa受体调节剂的用途
CN107750250B (zh) 2015-04-29 2021-09-07 詹森药业有限公司 吲哚酮化合物及其作为ampa受体调节剂的用途
AU2016255431B2 (en) * 2015-04-29 2020-05-07 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as AMPA receptor modulators
GB201702221D0 (en) 2017-02-10 2017-03-29 Univ Of Sussex Compounds
GB201803340D0 (en) 2018-03-01 2018-04-18 Univ Of Sussex Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2159479B1 (es) 1999-10-25 2002-05-01 Menarini Lab Nuevos indazoles como inhibidores de la ciclooxigenasa-ii
EP1781614B1 (de) 2004-08-09 2009-06-24 Glaxo Group Limited Verbindungen, die den glutamatrezeptor verstärken und anwendungen davon in der medizin

Also Published As

Publication number Publication date
EP2086643A1 (de) 2009-08-12
ATE502675T1 (de) 2011-04-15
JP2010508328A (ja) 2010-03-18
EP2086643B1 (de) 2011-03-23
WO2008053031A1 (en) 2008-05-08
US20100137276A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
DE602007013450D1 (de) Verbindungen, die den ampa-rezeptor verstärken, und deren anwendung in der medizin
EA200802007A1 (ru) Соединения, потенцирующие рецептор амра, и применение указанных соединений в медицине
CY1119176T1 (el) 5-υποκατεστημενα παραγωγα κιναζολινονης ως αντικαρκινικοι παραγοντες
GB0612423D0 (en) Therapeutic agents
SE0402735D0 (sv) Novel compounds
MY145647A (en) (4-hydroxy-2-oxo-3h-benzothiazol-7-yl)ethylamine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy (for example in the treatment of respiratory disease states)
NZ595738A (en) Benzimidazole-piperidine-cyclohexane derivatives which have activity at M1 receptor and their uses in medicine
WO2007087548A3 (en) Chemical compounds
EA200701324A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
DE602005017895D1 (de) Pyrazolamid-derivate, diese verbindungen enthaltende zusammensetzungen und anwendungsverfahren
TW200640908A (en) Chemical compounds
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
EA200801184A1 (ru) Производные пипередин-4-ил-пиридазин-3-иламина как быстро диссоциирующие антагонисты рецептора дофамина 2
NO20080670L (no) Substituerte piperaziner som metabotrofiske glutamatreseptorantagonister
TW200736189A (en) Indene derivatives, their preparation and use as medicaments
CY1112391T1 (el) Υποκατεστημενες ν-φαινυλ-διπυρρολιδινη ουριες και θεραπευτικες χρησεις αυτων
DE602008004540D1 (de) 2-oxo-2-(2-phenyl-5,6,7,8-tetrahydroindolizin-3-yl)acetamidderivate und verwandte verbindungen als antipilzmittel
MX2009013501A (es) Compuestos piperidinicos y sus usos.
MX339644B (es) Sales de xantilio 3,6-disustituidas.
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
WO2022261240A3 (en) Dimethoxyphenylalkylamine activators of serotonin receptors
AU2022376760A1 (en) Piperidinyl indole derivatives, preparation methods and medicinal uses thereof
WO2006018708A3 (en) Pyrrolidine derivatives as muscarinic receptor antagonists
NO20091832L (no) Indoler som virker via reseptorantagonister
DE60327323D1 (de) Chinazoline derivative und ihre anwendung in der krebsbehandlung